With Saline in Short Supply, Hospitals Look for Alternatives

Lena J. Weiner, for HealthLeaders Media , May 16, 2014

Wayne Russell, senior director of pharmacy at Premier, Inc., a group purchasing organization, has a similar take. "My view is not the same as the FDA's. The FDA has said the shortage was caused by an increased number of flu cases and extra hospitalizations… and use of fluids, but I can tell you that every manufacturer of IV fluids in the US has had recent [manufacturing related] quality issues."

Russell says those quality issues necessitated a manufacturing slowdown and "they still haven't caught up with demand."

A High Price to Pay
Whatever the cause of the shortage, its effect is hitting hospital budgets. Jaspan's longtime supplier, proposed a price hike of "300%—that would have been my increase had I stayed with Hospira," says Jaspan. He found an alternate vendor.

When substitution or careful rationing of saline isn't enough, organizations can expect to feel the pinch when paying for saline. "The product being imported to the US is about ten times higher than [what hospitals are accustomed to paying], said Russell.

So far, the FDA has given a major European manufacturer of saline, Fresenius Kabi, permission to export saline manufactured in Norway to the US, and is allowing Baxter to supplement its normal supplies with saline manufactured in its plant in Spain.

It must be distributed through the normal channels and "it's being very tightly managed," says Russell.

The manufacturers have handled allocation and distribution of saline throughout the shortage. "They try to fairly distribute it. If they didn't do that, you would have some hospitals buying more than they need and hoarding it," he said.

1 | 2 | 3 | 4 | 5

Comments are moderated. Please be patient.

3 comments on "With Saline in Short Supply, Hospitals Look for Alternatives"

Janet Mlinar (5/20/2014 at 1:32 AM)
I agree with making or at least storing large quantities of IV saline in hospital pharmacies. Along with reusing the same IV bag with the same patient. As long as sterile refills are applied. We have a growing population of people worldwide. Part of keeping up with this demand is having large quantities of what we know we will need at hand or at least having the capability of making or compounding medications as needed.

MB Rosenstiel, RN, DNP (5/16/2014 at 2:38 PM)
Seems to a clear move to increase the cost of a relatively inexpensive healthcare item to me. Perhaps it is time for pharmD's to compound in-house and use all the education they recieved. Might actually be less expensive and safer in the end!

David Morledge, PhD (5/16/2014 at 10:27 AM)
A broken system. Clearly we need a national security initiative related to basic healthcare supply systems, with requisite manufacturing in the U.S.




FREE e-Newsletters Join the Council Subscribe to HL magazine


100 Winners Circle Suite 300
Brentwood, TN 37027


About | Advertise | Terms of Use | Privacy Policy | Reprints/Permissions | Contact
© HealthLeaders Media 2015 a division of BLR All rights reserved.